Nektar Bounces Back As Eczema Drug Rezpeg Heads For Phase III

Scratching
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Therapy Areas